Ignite Creation Date:
2024-05-06 @ 3:14 PM
Last Modification Date:
2024-10-26 @ 1:45 PM
Study NCT ID:
NCT04566952
Status:
UNKNOWN
Last Update Posted:
2020-10-30
First Post:
2020-09-24
Brief Title:
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
Sponsor:
Organization:
Jiangsu Cancer Institute Hospital